A Spanish version the page you have requested doesn't exist. Please click continue to to be navigated to the page, or click Cancel to remain on the current page.

Jill O'Donnell-Tormey, Ph.D.

CRI BlogAuthors
Let's spread the word about Immunotherapy! Click to share this page with your community.
CICON

CICON22 Day 4 Highlights

October 2, 2022Arthur N. Brodsky, Ph.D.

Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.

Read More

Filter by:

Recent Posts
research CRI Impact technology immune system CRI LJO STARs immunology Message from the CEO cri scientists genetics and genomics

CRI Scientist's "Rosetta Stone" Tech

Jill O'Donnell-Tormey, Ph.D.
February 10, 2022
Message from the CEO

Message from CRI Regarding #ShutDownSTEM

Jill O'Donnell-Tormey, Ph.D.
June 10, 2020
COVID-19 immunology Message from the CEO

Message from CRI Regarding COVID-19

Jill O'Donnell-Tormey, Ph.D.
March 18, 2020
in the news

CRI Meets with the Vice President's Staff on Moonshot

Jill O'Donnell-Tormey, Ph.D.
February 26, 2016
history

William Coley and Cancer Immunotherapy Spotlighted on NPR

Jill O'Donnell-Tormey, Ph.D.
December 28, 2015

*Immunotherapy results may vary from patient to patient.

Contact Us

Cancer Research Institute | National Headquarters
29 Broadway, Floor 4 | New York, NY 10006-3111

800-992-2623212-832-9376Staff Directory

Stay Connected with CRI

Follow us

Recent Blog Posts

Dr. Benjamin Vincent recaps highlights from Day 4 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference, covering cancer vaccines and innovative technologies to study tumor immunity.

Dr. E. John Wherry dicusses cell therapies and the cancer ecosystem during Day 3 of the 2022 CRI-ENCI-AACR International Cancer Immunotherapy Conference (CICON22).
Top